ID

22676

Descripción

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Palabras clave

Versiones (1)

1. 9/6/17 9/6/17 -

Titular de derechos de autor

Genentech, Inc.

Subido en

9 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia